{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T13:08:05Z","timestamp":1776172085403,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2011,7,22]],"date-time":"2011-07-22T00:00:00Z","timestamp":1311292800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1007\/s11064-011-0541-z","type":"journal-article","created":{"date-parts":[[2011,7,21]],"date-time":"2011-07-21T12:49:16Z","timestamp":1311252556000},"page":"2169-2175","source":"Crossref","is-referenced-by-count":24,"title":["Quinoprotein Adducts Accumulate in the Substantia Nigra of Aged Rats and Correlate with Dopamine-Induced Toxicity in SH-SY5Y Cells"],"prefix":"10.1007","volume":"36","author":[{"given":"Na","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guohua","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chonggang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiyan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,7,22]]},"reference":[{"key":"541_CR1","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","volume":"5","author":"LM Lau de","year":"2006","unstructured":"de Lau LM, Breteler MM (2006) Epidemiology of Parkinson\u2019s disease. Lancet Neurol 5:525\u2013535","journal-title":"Lancet Neurol"},{"key":"541_CR2","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1056\/NEJM2003ra020003","volume":"348","author":"RL Nussbaum","year":"2003","unstructured":"Nussbaum RL, Ellis CE (2003) Alzheimer\u2019s disease and Parkinson\u2019s disease. N Engl J Med 348:1356\u20131364","journal-title":"N Engl J Med"},{"key":"541_CR3","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1073\/pnas.93.5.1956","volume":"93","author":"TG Hastings","year":"1996","unstructured":"Hastings TG, Lewis DA, Zigmond MJ (1996) Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections. Proc Natl Acad Sci USA 93:1956\u20131961","journal-title":"Proc Natl Acad Sci USA"},{"key":"541_CR4","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1111\/j.1460-9568.2006.05143.x","volume":"24","author":"RE Colebrooke","year":"2006","unstructured":"Colebrooke RE et al (2006) Age-related decline in striatal dopamine content and motor performance occurs in the absence of nigral cell loss in a genetic mouse model of Parkinson\u2019s disease. Eur J Neurosci 24:2622\u20132630","journal-title":"Eur J Neurosci"},{"key":"541_CR5","doi-asserted-by":"crossref","first-page":"8138","DOI":"10.1523\/JNEUROSCI.0319-07.2007","volume":"27","author":"WM Caudle","year":"2007","unstructured":"Caudle WM et al (2007) Reduced vesicular storage of dopamine causes progressive nigrostriatal neurodegeneration. J Neurosci 27:8138\u20138148","journal-title":"J Neurosci"},{"key":"541_CR6","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1523\/JNEUROSCI.3602-07.2008","volume":"28","author":"L Chen","year":"2008","unstructured":"Chen L et al (2008) Unregulated cytosolic dopamine causes neurodegeneration associated with oxidative stress in mice. J Neurosci 28:425\u2013433","journal-title":"J Neurosci"},{"key":"541_CR7","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.neuron.2009.01.033","volume":"62","author":"EV Mosharov","year":"2009","unstructured":"Mosharov EV et al (2009) Interplay between cytosolic dopamine, calcium, and alpha-synuclein causes selective death of substantia nigra neurons. Neuron 62:218\u2013229","journal-title":"Neuron"},{"key":"541_CR8","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1124\/pr.56.3.1","volume":"56","author":"G Eisenhofer","year":"2004","unstructured":"Eisenhofer G, Kopin IJ, Goldstein DS (2004) Catecholamine metabolism: a contemporary view with implications for physiology and medicine. Pharmacol Rev 56:331\u2013349","journal-title":"Pharmacol Rev"},{"key":"541_CR9","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.tins.2008.02.010","volume":"31","author":"WM Caudle","year":"2008","unstructured":"Caudle WM et al (2008) Altered vesicular dopamine storage in Parkinson\u2019s disease: a premature demise. Trends Neurosci 31:303\u2013308","journal-title":"Trends Neurosci"},{"key":"541_CR10","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0026-895X(25)13535-9","volume":"14","author":"DG Graham","year":"1978","unstructured":"Graham DG (1978) Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. Mol Pharmacol 14:633\u2013643","journal-title":"Mol Pharmacol"},{"key":"541_CR11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF03033289","volume":"1","author":"D Sulzer","year":"2000","unstructured":"Sulzer D, Zecca L (2000) Intraneuronal dopamine-quinone synthesis: a review. Neurotox Res 1:181\u2013195","journal-title":"Neurotox Res"},{"key":"541_CR12","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1021\/tx9902082","volume":"13","author":"JL Bolton","year":"2000","unstructured":"Bolton JL et al (2000) Role of quinones in toxicology. Chem Res Toxicol 13:135\u2013160","journal-title":"Chem Res Toxicol"},{"key":"541_CR13","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1046\/j.1471-4159.1996.67020593.x","volume":"67","author":"SB Berman","year":"1996","unstructured":"Berman SB, Zigmond MJ, Hastings TG (1996) Modification of dopamine transporter function: effect of reactive oxygen species and dopamine. J Neurochem 67:593\u2013600","journal-title":"J Neurochem"},{"key":"541_CR14","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1046\/j.1471-4159.1999.0731127.x","volume":"73","author":"SB Berman","year":"1999","unstructured":"Berman SB, Hastings TG (1999) Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson\u2019s disease. J Neurochem 73:1127\u20131137","journal-title":"J Neurochem"},{"key":"541_CR15","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1038\/nm1314","volume":"11","author":"MJ LaVoie","year":"2005","unstructured":"LaVoie MJ et al (2005) Dopamine covalently modifies and functionally inactivates parkin. Nat Med 11:1214\u20131221","journal-title":"Nat Med"},{"key":"541_CR16","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1146\/annurev.ne.12.030189.002215","volume":"12","author":"RE Zigmond","year":"1989","unstructured":"Zigmond RE, Schwarzschild MA, Rittenhouse AR (1989) Acute regulation of tyrosine hydroxylase by nerve activity and by neurotransmitters via phosphorylation. Annu Rev Neurosci 12:415\u2013461","journal-title":"Annu Rev Neurosci"},{"key":"541_CR17","doi-asserted-by":"crossref","first-page":"5650","DOI":"10.1016\/S0021-9258(19)67644-1","volume":"266","author":"JW Haycock","year":"1991","unstructured":"Haycock JW, Haycock DA (1991) Tyrosine hydroxylase in rat brain dopaminergic nerve terminals. Multiple-site phosphorylation in vivo and in synaptosomes. J Biol Chem 266:5650\u20135657","journal-title":"J Biol Chem"},{"key":"541_CR18","doi-asserted-by":"crossref","first-page":"5349","DOI":"10.1523\/JNEUROSCI.4107-06.2007","volume":"27","author":"D Zhang","year":"2007","unstructured":"Zhang D et al (2007) Protein kinase C delta negatively regulates tyrosine hydroxylase activity and dopamine synthesis by enhancing protein phosphatase-2A activity in dopaminergic neurons. J Neurosci 27:5349\u20135362","journal-title":"J Neurosci"},{"key":"541_CR19","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0021-9258(17)35225-0","volume":"266","author":"MA Paz","year":"1991","unstructured":"Paz MA et al (1991) Specific detection of quinoproteins by redox-cycling staining. J Biol Chem 266:689\u2013692","journal-title":"J Biol Chem"},{"key":"541_CR20","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1111\/j.1471-4159.2009.06394.x","volume":"111","author":"A Tarozzi","year":"2009","unstructured":"Tarozzi A et al (2009) Sulforaphane as an inducer of glutathione prevents oxidative stress-induced cell death in a dopaminergic-like neuroblastoma cell line. J Neurochem 111:1161\u20131171","journal-title":"J Neurochem"},{"key":"541_CR21","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.bbagen.2008.08.005","volume":"1790","author":"AM Snyder","year":"2009","unstructured":"Snyder AM, Connor JR (2009) Iron, the substantia nigra and related neurological disorders. Biochim Biophys Acta 1790:606\u2013614","journal-title":"Biochim Biophys Acta"},{"key":"541_CR22","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0006-8993(03)02275-3","volume":"969","author":"L Giovannelli","year":"2003","unstructured":"Giovannelli L et al (2003) Vulnerability to DNA damage in the aging rat substantia nigra: a study with the comet assay. Brain Res 969:244\u2013247","journal-title":"Brain Res"},{"issue":"Suppl 1","key":"541_CR23","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/S1353-8020(09)70010-0","volume":"15","author":"N Hattoria","year":"2009","unstructured":"Hattoria N et al (2009) Toxic effects of dopamine metabolism in Parkinson\u2019s disease. Parkinsonism Relat Disord 15(Suppl 1):S35\u2013S38","journal-title":"Parkinsonism Relat Disord"},{"key":"541_CR24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jns.2005.08.016","volume":"240","author":"A Agil","year":"2006","unstructured":"Agil A et al (2006) Plasma lipid peroxidation in sporadic Parkinson\u2019s disease. Role of the L-dopa. J Neurol Sci 240:31\u201336","journal-title":"J Neurol Sci"},{"key":"541_CR25","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0022-510X(73)90175-5","volume":"20","author":"H Bernheimer","year":"1973","unstructured":"Bernheimer H et al (1973) Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci 20:415\u2013455","journal-title":"J Neurol Sci"},{"key":"541_CR26","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.neuro.2009.12.003","volume":"31","author":"A Kanthasamy","year":"2010","unstructured":"Kanthasamy A et al (2010) Novel cell death signaling pathways in neurotoxicity models of dopaminergic degeneration: relevance to oxidative stress and neuroinflammation in Parkinson\u2019s disease. Neurotoxicology 31:555\u2013561","journal-title":"Neurotoxicology"},{"key":"541_CR27","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1006\/exnr.1996.6374","volume":"143","author":"KR Hoyt","year":"1997","unstructured":"Hoyt KR, Reynolds IJ, Hastings TG (1997) Mechanisms of dopamine-induced cell death in cultured rat forebrain neurons: interactions with and differences from glutamate-induced cell death. Exp Neurol 143:269\u2013281","journal-title":"Exp Neurol"},{"key":"541_CR28","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1046\/j.1471-4159.1997.69031185.x","volume":"69","author":"SB Berman","year":"1997","unstructured":"Berman SB, Hastings TG (1997) Inhibition of glutamate transport in synaptosomes by dopamine oxidation and reactive oxygen species. J Neurochem 69:1185\u20131195","journal-title":"J Neurochem"},{"key":"541_CR29","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0169-328X(99)00238-7","volume":"73","author":"DM Kuhn","year":"1999","unstructured":"Kuhn DM, Arthur RE Jr (1999) L-DOPA-quinone inactivates tryptophan hydroxylase and converts the enzyme to a redox-cycling quinoprotein. Brain Res Mol Brain Res 73:78\u201384","journal-title":"Brain Res Mol Brain Res"},{"key":"541_CR30","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1046\/j.1471-4159.1999.0731309.x","volume":"73","author":"DM Kuhn","year":"1999","unstructured":"Kuhn DM et al (1999) Tyrosine hydroxylase is inactivated by catechol-quinones and converted to a redox-cycling quinoprotein: possible relevance to Parkinson\u2019s disease. J Neurochem 73:1309\u20131317","journal-title":"J Neurochem"},{"key":"541_CR31","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.bbadis.2005.03.013","volume":"1741","author":"FH Khan","year":"2005","unstructured":"Khan FH et al (2005) Inhibition of rat brain mitochondrial electron transport chain activity by dopamine oxidation products during extended in vitro incubation: implications for Parkinson\u2019s disease. Biochim Biophys Acta 1741:65\u201374","journal-title":"Biochim Biophys Acta"},{"key":"541_CR32","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.nbd.2009.03.004","volume":"34","author":"VS Laar Van","year":"2009","unstructured":"Van Laar VS et al (2009) Proteomic identification of dopamine-conjugated proteins from isolated rat brain mitochondria and SH-SY5Y cells. Neurobiol Dis 34:487\u2013500","journal-title":"Neurobiol Dis"},{"key":"541_CR33","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0006-8993(00)03284-4","volume":"895","author":"FH Khan","year":"2001","unstructured":"Khan FH, Saha M, Chakrabarti S (2001) Dopamine induced protein damage in mitochondrial-synaptosomal fraction of rat brain. Brain Res 895:245\u2013249","journal-title":"Brain Res"},{"key":"541_CR34","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.bbadis.2011.02.013","volume":"1812","author":"S Jana","year":"2011","unstructured":"Jana S et al (2011) Mitochondrial dysfunction mediated by quinone oxidation products of dopamine: Implications in dopamine cytotoxicity and pathogenesis of Parkinson\u2019s disease. Biochim Biophys Acta 1812:663\u2013673","journal-title":"Biochim Biophys Acta"},{"key":"541_CR35","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1126\/science.1063522","volume":"294","author":"KA Conway","year":"2001","unstructured":"Conway KA et al (2001) Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct. Science 294:1346\u20131349","journal-title":"Science"},{"key":"541_CR36","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1007\/s11064-008-9843-1","volume":"34","author":"I Miyazaki","year":"2009","unstructured":"Miyazaki I, Asanuma M (2009) Approaches to prevent dopamine quinone-induced neurotoxicity. Neurochem Res 34:698\u2013706","journal-title":"Neurochem Res"},{"key":"541_CR37","doi-asserted-by":"crossref","first-page":"5003","DOI":"10.1016\/j.febslet.2007.09.046","volume":"581","author":"I Miyazaki","year":"2007","unstructured":"Miyazaki I et al (2007) Protective effects of metallothionein against dopamine quinone-induced dopaminergic neurotoxicity. FEBS Lett 581:5003\u20135008","journal-title":"FEBS Lett"},{"key":"541_CR38","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.neures.2007.10.002","volume":"60","author":"M Asanuma","year":"2008","unstructured":"Asanuma M et al (2008) Preventing effects of a novel anti-parkinsonian agent zonisamide on dopamine quinone formation. Neurosci Res 60:106\u2013113","journal-title":"Neurosci Res"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-011-0541-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11064-011-0541-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-011-0541-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T07:18:36Z","timestamp":1741331916000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11064-011-0541-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,22]]},"references-count":38,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["541"],"URL":"https:\/\/doi.org\/10.1007\/s11064-011-0541-z","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,22]]}}}